GENE ONLINE|News &
Opinion
Blog

2025-08-12| Trials & Approvals

FDA Approval of First-in-Class BRINSUPRI Offers New Hope for Hundreds of Thousands with Chronic Lung Disease

by Denisse Sandoval
Share To
The U.S. Food and Drug Administration (FDA) has approved Insmed’s oral drug BRINSUPRI (brensocatib) as the first treatment for non-cystic fibrosis bronchiectasis (NCFB) in patients …

FDA Approval of First-in-Class BRINSUPRI Offers New Hope for Hundreds of Thousands with Chronic Lung Disease Read More »

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
North Star Review Board Launches Nonprofit Model for Institutional Oversight
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
106 Adults Receive Free Dementia Screenings at Atlanta Community Organizations
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
Boston College Chemist Receives $600,000 NSF Grant to Study Transition Metal Oxychlorides for Battery Storage
2026-08-10
Researchers Identify Related Viruses to Mitigate Koi Herpesvirus in Carp Populations
2026-08-10
READ MORE
EVENT
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
SEE MORE
Scroll to Top